MedTrace Logo

Safety of Donepezil in Patients With Dementia Associated With Cerebrovascular Disease

NCT00188812 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2009-01-12

No results posted yet for this study

Summary

one year extension study following a previous double-blind study to evaluate safety of the drug

Conditions

  • Dementia Associated With Cerebrovascular Disease

Interventions

DRUG

donepezil hcl

Sponsors & Collaborators

  • Eisai Inc.

    collaborator INDUSTRY

  • University Health Network, Toronto

    lead OTHER

Principal Investigators

  • Karl Farcnik, MD FRCP(C) · University Health Network, Toronto

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-05-31
Completion
2005-08-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00188812 on ClinicalTrials.gov